Satellite Banner
Technology Networks Header
Saturday, October 25, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Agilent Introduces SureSelect Focused Exome Kit
Saturday, October 25, 2014
Solution ideal for both high-throughput and benchtop next-generation sequencing applications.

NIBMG Accelerates Oral Cancer Research Using DDN Storage
Friday, October 24, 2014
India’s first biomedical genomics institute relies on DDN’s exceptional performance and complete end-to-end file and object solution for big data ingest, processing, collaboration and archive.

DNA Sequencing Analysis Kits Added to HIPAA Compliant Maverix Analytic Platform
Monday, October 20, 2014
Highly scalable analysis solutions for large volumes of whole genome, exome, and targeted resequencing data.

Illumina Launches New Reagent Kits for HiSeq X Ten and HiSeq 2500 Systems
Saturday, October 18, 2014
Enhancements offer improved performance for high throughput sequencing.

OGT Launches Medical Research Exome Array at ASHG
Wednesday, October 15, 2014
Hand-curated array provides complete coverage of over 4600 medically relevant genes.

IDT Launches Modular NGS Gene Capture Pools
Wednesday, October 15, 2014
Easy access to customizable and cost-effective target capture.

Era7 Launches its New Service Genome7
Wednesday, October 15, 2014
An integrated solution for Cancer Genomics.

Tecan Offers NGS Sample Preparation at the Touch of a Button
Friday, September 19, 2014
Tecan’s Freedom EVO NGS workstation to offer robust and reliable automation.

High Throughput Biological Sample Concentrator
Tuesday, September 16, 2014
The miVac Quattro from Genevac is the perfect workhorse sample concentrator for biological laboratories tasked with handling larger numbers of samples.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 213
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv